Makes Imcivree, a drug for rare genetic forms of severe obesity.
New: first time
Duquesne bought Rhythm Pharmaceuticals for the first time between April and June: 203,618 shares, worth about $23 million. That’s already less than $1 of every $100 they have in stocks.
Mar 31
None
Jun 30
203,618
The numbers
Shares they own
203,618
Value on Jun 30, 2026
$22,608,000
about $23 million
Share of their money
0.5%
less than $1 of every $100 · 38th of 85
Price per share on Jun 30
$111.03
Kind
Shares
Also owned by
No other fund we follow
More about Rhythm Pharmaceuticals ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.